Brevan Howard Capital Management’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $622K | Buy |
|
|||||
|
2025
Q1 | $358K | Buy |
|
|||||
|
2024
Q4 | $88.5K | Sell |
|
|||||
|
2024
Q3 | $320K | Buy |
|
|||||
|
2024
Q2 | $191K | Sell |
|
|||||
|
2024
Q1 | $3.46M | Sell |
|
|||||
|
2023
Q4 | $5.63M | Sell |
|
|||||
|
2023
Q3 | $7.11M | Buy |
|
|||||
|
2023
Q2 | $10.4M | Buy |
|
|||||
|
2023
Q1 | $3.26M | Buy |
|
|||||
|
2022
Q4 | $1.79M | Hold |
|
|||||
|
2022
Q3 | $2.68M | Buy |
|
|||||
|
2022
Q2 | $2.25M | Buy |
|